Extended Data Fig. 1: Post hoc subgroup analysis of pCR between Cam+nab-TP group and TP group. | Nature Medicine

Extended Data Fig. 1: Post hoc subgroup analysis of pCR between Cam+nab-TP group and TP group.

From: Neoadjuvant chemotherapy with or without camrelizumab in resectable esophageal squamous cell carcinoma: the randomized phase 3 ESCORT-NEO/NCCES01 trial

Extended Data Fig. 1

The central points on each bar represent the mean difference in pCR rates between the two groups, while the bars indicate the 95% CI. pCR, pathological complete response; ECOG PS, Eastern Cooperative Oncology Group performance status; TPS, tumor proportion score; CPS, combined positive score; CI, confidence interval.

Back to article page